Each year, nearly 40,000 Americans die often painful, protracted deaths from diseases caused by asbestos. These deaths occur in firefighters, police officers, construction workers, miners, military veterans, shipyard workers, and maintenance workers whose exposures to asbestos are primarily occupational. Death also occurs in partners and children … [Read more...]
Malignant pleural mesothelioma: from bedside to bench and from bench to bedside
Malignant pleural mesothelioma (MPM) is a rare but very aggressive cancer of the thin tissue layer (pleura) covering the lungs. The development of MPM is strongly linked to previous exposure to the fibrous mineral asbestos, which has been widely used until the 1980s, in particular in the building industry. Although patients are generally eligible … [Read more...]
NIOSH considers mesothelioma registry; seeks input
The [ National Institute for Occupational Safety and Health (NIOSH) ] is gauging the feasibility of a national [ mesothelioma registry ] intended to track cases of mesothelioma, a rare form of cancer linked to on-the-job exposure to asbestos. According to a Request for Information published in the April 8 Federal Register, the agency is asking … [Read more...]
More than 200 teachers died from asbestos – and kids are at risk in classroom
More than 200 teachers have died in the past 10 years from the effects of being exposed to asbestos. And for each teacher fatality, nine ex-pupils can also be expected to fall victim to the silent killer, a study claims – an average of almost 200 per year. Breathing in asbestos fibres can lead to mesothelioma, a cancer that develops in the … [Read more...]
Dr. Goldberg Discusses the Diagnosis of Mesothelioma (Short Video)
Sarah B. Goldberg, MD, MPH, assistant professor of medicine, Yale School of Medicine and Yale Cancer Center, discusses the diagnosis of mesothelioma. This is an extremely rare disease that is usually seen in patients with prior asbestos exposure, Goldberg says. However, mesothelioma can be seen occasionally in patients without prior exposure to … [Read more...]
Avelumab may benefit some patients with advanced unresectable mesothelioma
The anti-programmed cell death ligand 1 (PD-L1) monoclonal antibody avelumab is well tolerated and shows antitumor activity in some patients with previously treated unresectable mesothelioma, according to results from a single-arm trial. “Immune-checkpoint inhibitors result in clinical benefit in a small subset of patients with mesothelioma, but … [Read more...]
Pleural mesothelioma: tackling a deadly cancer
A new study from the University of Pittsburgh has highlighted six factors that are associated with improved survival in patients with mesothelioma; age under 45 years, female, epithelioid histological subtype, peritoneal mesothelioma, stage 1 cancer, and being treated with both surgery and chemotherapy. This knowledge, together with recent reports … [Read more...]
J&J’s Risk From Tainted-Talc Lawsuits Only Gets Bigger in 2019
Johnson & Johnson paid a steep price this year for claims that its celebrated baby powder was contaminated with asbestos. Problem is, 2019 could be even worse. A jury ordered the company in July to pay $4.69 billion to 22 women who blamed the talc-based product for causing their ovarian cancer. The prospect of similar judgments helped erase … [Read more...]
Jury clears J&J of liability in California talc cancer case
A California jury on [November 14, 2018] cleared Johnson & Johnson of liability in a case involving a woman who alleged that the company’s talc-based products, including its baby powder, contain asbestos and caused her cancer, the company said. The jury in Humboldt County Superior Court in Eureka, California rejected claims by Carla Allen … [Read more...]
Differentiating epithelioid mesothelioma from lung adenocarcinoma — MUC21 is a novel, negative immunohistochemical marker
A recent medical study investigated the potential usefulness of mucin 21 (MUC21), as a novel, negative diagnostic marker for purpose of differentiating epithelioid mesothelioma from lung adenocarcinoma. In order to analyze the expression of MUC21 by immunohistochemistry, 70 epithelioid mesothelioma and 70 lung adenocarcinoma cases were examined. … [Read more...]